IntroductionCervical cancer is, after breast cancer, the second highest worldwide female malignancy. The incidence has been increasing gradually over recent years, with younger patients resulting affected. Thus, it is becoming one of the most deadly cancer globally [ 1 -4 ].The age-adjusted incidence rate rises rapidly in the third decade of life to approximately 20 cases per 100,000 and then increases slowly to 30 through the ninth decade. Although cervical cytology may potentially reduce the mortality rate of cervical cancer by 80 %, this procedure has only been fully implemented in few countries because of its costs and logistical problems resulting from the high incidence of cervical cancer precursors [ 5 ].Various types of radical surgery (RS), such as radical hysterectomy, radical trachelectomy, and radical parametrectomy, have shown 5-year survival rates ranging between 75 and 90 % [ 1 , 5 , 6 ], remaining the standard treatment for patients with early-stage cervical cancer [ 7 -9 ]. However, RS is known to cause urinary dysfunctions, such as bladder hypotonia, urinary incontinence, and abnormal sensation, in 12-85 % of patients [ 10 -12 ]. Furthermore, bowel dysfunctions, such as constipation, have been reported in 5-10 % of patients after RS [ 13 , 14 ].Considerable sexual dysfunctions, including decrease in sexual interest, orgasm, and vaginal dryness, may also be reported after RS. The sexual activity impairment thus results in substantial distress [ 15 ]. Urinary, anorectal, and sexual dysfunctions are known to be caused, during RS, by the disruption of sympathetic and parasympathetic